Last updated: 2026-09-05 03:45:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Autonomix Medical, Inc. (AMIX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4.55, with a market capitalization of $4.37M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.44 to $32.55. This page covers its latest market performance, valuation, price trends and company information.
$4.37M | |
$4.59 | |
$3,192.00 | |
$2.44 | |
$4.68 | |
61.74K | |
-- | |
-- | |
$32.55 | |
$2.44 | |
-- | |
-- |
Autonomix Medical, Inc. (AMIX) last closed at $4.68 as of 2026-09-05 00:00:00, unchanged from the previous close of $4.68.
During the latest regular trading session, AMIX traded between $2.44 and $3,192.00, with a volume of 61.74K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Autonomix Medical, Inc. (AMIX) moved from $5.20 to $4.55, representing a decline of 12.60% ($0.66).
The stock traded between $4.51 and $4.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 220.07 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 7.0%
AMIX is currently trading at $4.55, placing it 7.0% of the way from its 52-week low of $2.44 to its 52-week high of $32.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Autonomix Medical, Inc. (AMIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.